Features of the use of non-steroidal anti-inflammatory drugs in the treatment of fever: emphasis on safety


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Currently, despite the fact that already much information is available about the use of non-steroidal anti-inflammatory drugs (NSAIDs) in the pediatric population, the issues of safety of this group of drugs in children are still relevant. NSAIDs are most often used for fever in children. OTC NSAID dispensing leads to frequent problems: parents strongly try force to reduce the temperature of a febrile child to normal values, therefore side effects from the use of antipyretic drugs develop.

Full Text

Restricted Access

About the authors

E. P Smirnova

M.E. Zhadkevich City Clinical Hospital; Pirogov Medical University

Moscow, Russia; Moscow, Russia

Svetlana B. Erofeeva

Pirogov Medical University; Krasnogorsk City Hospital № 1

Email: erofsb@mail.ru
Cand. Sci. (Med.), Clinical Pharmacologist; Associate Professor, Department of Clinical Pharmacology 4, Karbyshev str., Krasnogorsk 143408, Moscow region, Russian Federation

References

  1. Section on Clinical Pharmacology and Therapeutics, Committee on Drugs, Sullivan J.E., Farrar H.C. Fever and antipyretic use in children. Pediatrics. 2011;127:580-87. doi: 10.1542/peds.2010-3852.
  2. Leroy S., Mosca A., Landre-Peigne C., et al. Ibuprofen in childhood: evidence-based review of efficacy and safety. Arch Pediatr. 2007;14:477-84. doi: 10.1016/j.arcped.2007.01.012.
  3. Bertille N., Pons G., Fournier-Charrière E., et al. National cross-sectional study of nonsteroidal anti-inflammatory drugs use highlights differences between parents and professionals and prompts safety concerns. Acta Paediatr. 2016;105:e543-48. doi: 10.1111/apa.13566.
  4. Локшина Э.Э. Современный взгляд на рациональную терапию лихорадки у детей. РМЖ. 2013;2:103.
  5. Chiappini E., Venturini E., Remaschi G., et al. Italian pediatric society panel for the management of fever in children. 2016 update of the Italian pediatric society guidelines for management of fever in children. J Pediatr. 2017;180:177-183. e1. doi: 10.1016/j.jpeds.2016.09.043.
  6. Kramer M.S., Naimark L.E., Roberts-Bräuer R., et al. Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin. Lancet. 1991;337:591-94. doi: 10.1016/0140-6736(91)91648-E.
  7. Crocetti M., Moghbeli N, Serwint J. Fever phobia revisited: have parental misconceptions about fever changed in 20 years? Pediatrics. 2001;107:1241-46. doi: 10.1542/peds.107.6.1241.
  8. Karwowska A., Nijssen-Jordan C., Johnson D., Davies H.D. Parental and health care provider understanding of childhood fever: a Canadian perspective. CJEM. 2002;4:394-400. doi: 10.1017/S1481803500007892.
  9. Bertille N., Purssell E., Hjelm N., et al. Symptomatic management of febrile illnesses in children: a systematic review and meta-analysis of parents' knowledge and behaviors and their evolution over time. Front Pediatr. 2018;6:279. doi: 10.3389/fped.2018.00279.
  10. Meremikwu M., Oyo-Ita A. Paracetamol for treating fever in children. Cochrane Database Syst Rev. 2002;2:CD003676. doi: 10.1002/14651858. CD003676.
  11. Narayan K., Cooper S., Morphet J., Innes K. Effectiveness of paracetamol versus ibuprofen administration in febrile children: a systematic literature review. J Paediatr Child Health. 2017;53:800-7. doi: 10.1111/jpc.13507.
  12. Southey E.R., Soares-Weiser K., Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin. 2009;25:2207-22. doi: 10.1185/03007990903116255.
  13. Pierce C.A., Voss B. Efficacy and safety of ibuprofen and acetaminophen in children and adults: a metaanalysis and qualitative review. Ann Pharmacother 2010;44:489-506. doi: 10.1345/aph.1M332.
  14. Kanabar D.J. A clinical and safety review of paracetamol and ibuprofen in children. Inflammopharmacology. 2017;25:1-9. doi: 10.1007/s10787-016-0302-3.
  15. Chiappini E., D'Elios S., Mazzantini R., et al. Adherence among Italian paediatricians to the Italian guidelines for the management of fever in children: a cross sectional survey. BMC Pediatr. 2013;13:210. doi: 10.1186/1471-2431-13-210.
  16. Lava S.A., Simonetti G.D., Ramelli G.P., et al. Symptomatic management of fever by Swiss board-certified pediatricians: results from a cross-sectional, Web-based survey. Clin Ther. 2012;34:250-56. doi: 10.1016/j.clinthera.2011.12.002.
  17. Demir F., Sekreter O. Knowledge, attitudes and misconceptions of primary care physicians regarding fever in children: a cross sectional study. Ital J Pediatr. 2012;38:40. doi: 10.1186/1824-7288-38-40.
  18. Dfez Domingo J., Burgos Ramirez A., Garrido Garcia J., et al. [Use of alternating antipyretics in the treatment of fever in Spain]. An Esp Pediatr. 2001;55:503-10. doi: 10.1016/S1695-4033(01)77729-6).
  19. Trippella G., Ciarcià M., de Martino M., Chiappini E. Prescribing Controversies: An Updated Review and Meta-Analysis on Combined/Alternating Use of Ibuprofen and Paracetamol in Febrile Children. Front. Pediatr. 2019;7:217. doi: 10.3389/fped.2019.00217.
  20. Valkhoff V.E. NSAID use among children in Europe in the SOS project. May 2012. Conference: Gastroenterology. 2012; 142(5):S499. doi: 10.1016/S0016-5085(12)61911-8.
  21. Coxib and Traditional NSAID Trialists' (CNT) Collaboration, Bhala N., Emberson J., Merhi A., et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: metaanalyses of individual participant data from randomised trials. Lancet. 2013;382:769-79. doi: 10.1016/S0140-6736(13)60900-9.
  22. Perazella M.A. Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinician. Clin Nephrol. 2014;81:381-88. doi: 10.5414/CN108301.
  23. Patzer L. Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol. 2008;23:2159-73. doi: 10.1007/s00467-007-0721-x.
  24. Ulinski T., Sellier-Leclerc A.-L., Tudorache E., et al. Acute tubulointerstitial nephritis. Pediatr Nephrol. 2012;27:1051-57. doi: 10.1007/s00467-011-1915-9.
  25. Figueiredo A.C., Rodrigues I., Sousa V., Alves R. Granulomatous interstitial nephritis: a rare diagnosis with an overlooked culprit. BMJ Case Rep. 2019;12:e229159. doi: 10.1136/bcr-2018-229159.
  26. Rossert J. Drug-induced acute interstitial nephritis. Kidney Int. 2001;60:804-17. doi: 10.1046/j.1523-1755.2001.060002804.x.
  27. Jahnukainen T., Ala-Houhala M., Karikoski R., et al. Clinical outcome and occurrence of uveitis in children with idiopathic tubulointerstitial nephritis. Pediatr Nephrol. 2011;26:291-99. doi: 10.1007/s00467-010-1698-4.
  28. ClavéS.,Rousset-RouvièreC.,DanielL.,TsimaratosM. The Invisible Threat of Non-steroidal Antiinflammatory Drugs for Kidneys. Front Pediatr. 2019;7:520. doi: 10.3389/fped.2019.00520.
  29. Bensman A. Non-steroidal Anti-inflammatory Drugs (NSAIDs) Systemic Use: The Risk of Renal Failure. Front Pediatr. 2020;7:517. doi: 10.3389/fped.2019.00517.
  30. Misurac J.M., Knoderer C.A., Leiser J.D., et al. Nonsteroidal anti-inflammatory drugs are an important cause of acute kidney injury in children. J Pediatric. 2013;162:1153-59. doi: 10.1016/j.jpeds.2012.11.069.
  31. Musu M., Finco G., Antonucci R., et al. Acute nephrotoxicity of NSAID from the fœ tus to the adult. Eur Rev Med Pharmacol Sci. 2011;15:1461-72.
  32. Ulinski T., Guigonis V., Dunan O., Bensman A. Acute renal failure after treatment with nonsteroidal anti-inflammatory drugs. Eur J Pediatr. 2004;163:148:50. doi: 10.1007/s00431-003-1392-7).
  33. Raghavan R., Shawar S. Mechanisms of drug-induced interstitial nephritis. Adv Chronic Kidney Dis. 2017;24:64-71. doi: 10.1053/j.ackd.2016.11.004.
  34. Atiquzzaman M., Karim M.E., Kopec J., et al. Role of non-steroidal anti-inflammatory drugs (NSAIDs) in the association between osteoarthritis and cardiovascular diseases: a longitudinal study. Arthritis Rheumatol. 2019;71:1835-43. doi: 10.1002/art.41027.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Bionika Media